I am sharing a flock notice on a biotech visitors I plans up with that is implicated in the enlarge of a psychoanalysis that targets cancer. I am sharing less because of the investment explication but more repayment for the humanitarian ...
I am sharing a press release on a biotech company I follow that is involved in the development of a therapy that targets cancer. I am sharing less because of the investment aspect but more for the humanitarian since I know individuals ...
Dendreon Corporation Announces Data on PROVENGE Potency and Long-Term Immune Responses in Androgen-Dependent Prostate Cancer. -- Data presented at 100th Annual Meeting of the American Association for Cancer Research -- ...
Another feather floated onto the camel’s back earlier today when Dendreon released an unusual Sunday press release announcing that data from an earlier Phase 3 Provenge study (not the just-completed IMPACT study) suggest “that PROVENGE® ...